D

Delix Therapeutics

26 employees

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Life Science

Date founded

2019

Funding rounds raised

Total raised

$70M

from 11 investors over 11 rounds

D

Delix Therapeutics raised $70M on September 27, 2021

Investors: re.Mind Capital, Presight Capital, Palo Santo, PsyMed Ventures, -, OMX Ventures, Saya Bio and RA Capital Management, L.P.

D

Delix Therapeutics raised $8M on September 4, 2020

Investors: OMX Ventures and Presight Capital

D

Delix Therapeutics raised undisclosed on September 1, 2020

Investors: -

FAQ